Aptevo Therapeutics Inc APVO 深 滬
交易中 09-19 12:26:16 美东时间
0.1866
+0.022
+13.37%
華盛通- 最 高0.1949
- 今 開0.171
- 成交量 227.02万股
- 最 低 0.162
- 昨 收 0.1646
- 總市值 175.79万
- 52周最高 21.56
- 市盈率 靜 --
- 換手率 24.10%
- 52周最低 0.141
- 委 比 -98.79%
- 總股本 942.05万
- 歷史最高 5106.64
- 量 比 0.66
- 振 幅 19.99%
- 歷史最低 0.162
- 每 手 1
- 風險率 4.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Intel Corporation (NASDAQ:INTC) rose sharply in today's pre-market tr...
09-17 17:48
快讯 | aptevo therapeutics：Apvo436改名为Mipletamig
Aptevo Therapeutics: Apvo436 Renamed as Mipletamig
08-13 20:14
快讯 | aptevo therapeutics：1B/2 "Rainier" 一线急性髓系白血病（AML）试验已启动。
Aptevo Therapeutics: Phase 1B/2 "Rainier" Frontline Acute Myeloid Leukemia (Aml...
08-13 20:13
Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
Aptevo's lead candidate APVO436 (mipletamig) to be evaluated in combination wit...
08-13 20:05
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
SEATTLE, WA / ACCESSWIRE / July 1, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO...
07-02 04:20
Aptevo Therapeutics announces $2.75M offering priced at-the-market
Aptevo Therapeutics (NASDAQ:APVO) has entered into securities purchase agreements with certain investors to purchase 5.34M shares of its common stock or pre-funded warrants in lieu thereof and warrant...
06-28 22:50
Aptevo Therapeutics files to sell 6.02M shares of common stock
Aptevo Therapeutics (NASDAQ:APVO) filed a prospectus related to the offer and sale of 6.02M shares of common stock. This prospectus is not an offer to sell. Filing More on Aptevo Therapeutics Seeking ...
06-15 04:43
Aptevo Participating in the BIO International Convention
SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO...
06-03 20:05
Aptevo Therapeutics GAAP EPS of -$9.95 beats by $2.90
Aptevo Therapeutics press release (NASDAQ:APVO): Q1 GAAP EPS of -$9.95 beats by $2.90. Aptevo had cash and cash equivalents as of March 31, 2024, totaling $10.3 million. On a proforma basis, cash, and...
05-08 23:25
